As of April 16, 2025, Haw Par (H02.SI) has a market cap of $2.11 billion USD. According to our data, Haw Par is ranked No.3895 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $2.11 B |
12.56%
|
Dec 31, 2024 | $1.87 B |
19.05%
|
Dec 29, 2023 | $1.57 B |
5.56%
|
Dec 30, 2022 | $1.49 B |
-13.34%
|
Dec 31, 2021 | $1.72 B |
8.61%
|
Dec 31, 2020 | $1.58 B |
-12.86%
|
Dec 31, 2019 | $1.82 B |
14.21%
|
Dec 31, 2018 | $1.59 B |
7.86%
|
Dec 29, 2017 | $1.48 B |
27.24%
|
Dec 30, 2016 | $1.16 B |
12.96%
|
Dec 31, 2015 | $1.03 B |
-0.74%
|
Dec 31, 2014 | $1.03 B |
7.79%
|
Dec 31, 2013 | $0.96 B |
35.77%
|
Dec 31, 2012 | $0.71 B |
31.83%
|
Dec 30, 2011 | $0.54 B |
-11.13%
|
Dec 31, 2010 | $0.60 B |
9.12%
|
Dec 30, 2009 | $0.55 B |
67.10%
|
Dec 31, 2008 | $0.33 B |
-47.47%
|
Dec 31, 2007 | $0.63 B |
2.69%
|
Dec 29, 2006 | $0.61 B |
42.10%
|
Dec 30, 2005 | $0.43 B |
3.34%
|
Dec 31, 2004 | $0.42 B |
19.71%
|
Dec 31, 2003 | $0.35 B |
42.20%
|
Dec 31, 2002 | $0.25 B |
-16.85%
|
Dec 31, 2001 | $0.30 B |
16.59%
|
Dec 29, 2000 | $0.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
Market Cap | = | H02.SI Stock Price | * | H02.SI Shares Outstanding |
= | $9.53 | * | 0.22 B | |
= | $2.11 B |